Showing results (261-270 of 4,703) with videos related to
Sort By:
Pageof 471
Therapeutic Drug Monitoring|December 1, 1987
Development of a radioimmunoassay procedure for mesoridazine and its comparison with a high-performance liquid chromatographic methodB S Chakraborty, E M Hawes, K K MidhaTherapeutic Drug Monitoring|January 1, 1987
The effect of hyperlipidemia on therapeutic drug assaysD M Baer, R A PaulsonTherapeutic Drug Monitoring|January 1, 1986
Single and multiple dose kinetics of a new antiepileptic drug, Org 6370, and its desmethyl metabolite, Org 6363I M Kapetanovic, W D Yonekawa, H J Kupferberg, et al.Therapeutic Drug Monitoring|January 1, 1986
Monitoring of pentobarbital plasma levels in critical care patients suffering from increased intracranial pressureG Heinemeyer, I Roots, R DennhardtTherapeutic Drug Monitoring|January 1, 1986
Circadian variation in steady-state trough theophylline concentrationsR C Reed, H J SchwartzTherapeutic Drug Monitoring|January 1, 1986
Comparison of the fluorescence polarization immunoassay and the microbiological assay methods for the determination of gentamicin concentration in human serumO S Tayeb, A T el-Tahawy, S I IslamTherapeutic Drug Monitoring|November 14, 1997
Caffeine in saliva after peroral intake: early sample collection as a possible source of errorW Biederbick, G Joseph, A Rump, et al.Therapeutic Drug Monitoring|November 14, 1997
Quantification of the O- and N-demethylated and the glucuronidated metabolites of codeine relative to the debrisoquine metabolic ratio in urine in ultrarapid, rapid, and poor debrisoquine hydroxylatorsQ Y Yue, C Alm, J O Svensson, et al.Therapeutic Drug Monitoring|November 14, 1997
Quick onset of severe abdominal pain after codeine in an ultrarapid metabolizer of debrisoquineP Dalén, C Frengell, M L Dahl, et al.Therapeutic Drug Monitoring|January 1, 1985
Stability of bupropion and its major metabolites in human plasmaS C Laizure, C L DeVanePageof 471